A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation

Abstract Reactive oxygen species with evoked immunotherapy holds tremendous promise for cancer treatment but has limitations due to its dependence on exogenous excitation and/or endogenous H2O2 and O2. Here we report a versatile oxidizing pentavalent bismuth(V) nanoplatform (NaBiVO3-PEG) can generat...

Full description

Saved in:
Bibliographic Details
Main Authors: Yizhang Tang, Xujiang Yu, Liangrui He, Meng Tang, Wenji Yue, Ruitong Chen, Jie Zhao, Qi Pan, Wanwan Li
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56110-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585573837045760
author Yizhang Tang
Xujiang Yu
Liangrui He
Meng Tang
Wenji Yue
Ruitong Chen
Jie Zhao
Qi Pan
Wanwan Li
author_facet Yizhang Tang
Xujiang Yu
Liangrui He
Meng Tang
Wenji Yue
Ruitong Chen
Jie Zhao
Qi Pan
Wanwan Li
author_sort Yizhang Tang
collection DOAJ
description Abstract Reactive oxygen species with evoked immunotherapy holds tremendous promise for cancer treatment but has limitations due to its dependence on exogenous excitation and/or endogenous H2O2 and O2. Here we report a versatile oxidizing pentavalent bismuth(V) nanoplatform (NaBiVO3-PEG) can generate reactive oxygen species in an excitation-free and H2O2- and O2-independent manner. Upon exposure to the tumor microenvironment, NaBiVO3-PEG undergoes continuous H+-accelerated hydrolysis with •OH and 1O2 generation through electron transfer-mediated BiV-to-BiIII conversion and lattice oxygen transformation. The simultaneous release of sodium counterions after endocytosis triggers caspase-1-mediated pyroptosis. NaBiVO3-PEG intratumorally administered initiates robust therapeutic efficacies against both primary and distant tumors and activates systemic immune responses to combat tumor metastasis. NaBiVO3-PEG intravenously administered can efficiently accumulate at the tumor site for further real-time computed tomography monitoring, immunotherapy, or alternative synergistic immune-radiotherapy. Overall, this work offers a nanomedicine based on high-valence bismuth(V) nanoplatform and underscores its great potential for cancer immunotherapy.
format Article
id doaj-art-76f27ed6656744cb8e44d3cec9543e58
institution Kabale University
issn 2041-1723
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-76f27ed6656744cb8e44d3cec9543e582025-01-26T12:41:30ZengNature PortfolioNature Communications2041-17232025-01-0116111910.1038/s41467-025-56110-7A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generationYizhang Tang0Xujiang Yu1Liangrui He2Meng Tang3Wenji Yue4Ruitong Chen5Jie Zhao6Qi Pan7Wanwan Li8State Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadState Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadState Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadDepartment of Comprehensive Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College 17 Panjiayuan South LaneState Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadState Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadState Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadDepartment of Urology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine 85 Wujin RoadState Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan RoadAbstract Reactive oxygen species with evoked immunotherapy holds tremendous promise for cancer treatment but has limitations due to its dependence on exogenous excitation and/or endogenous H2O2 and O2. Here we report a versatile oxidizing pentavalent bismuth(V) nanoplatform (NaBiVO3-PEG) can generate reactive oxygen species in an excitation-free and H2O2- and O2-independent manner. Upon exposure to the tumor microenvironment, NaBiVO3-PEG undergoes continuous H+-accelerated hydrolysis with •OH and 1O2 generation through electron transfer-mediated BiV-to-BiIII conversion and lattice oxygen transformation. The simultaneous release of sodium counterions after endocytosis triggers caspase-1-mediated pyroptosis. NaBiVO3-PEG intratumorally administered initiates robust therapeutic efficacies against both primary and distant tumors and activates systemic immune responses to combat tumor metastasis. NaBiVO3-PEG intravenously administered can efficiently accumulate at the tumor site for further real-time computed tomography monitoring, immunotherapy, or alternative synergistic immune-radiotherapy. Overall, this work offers a nanomedicine based on high-valence bismuth(V) nanoplatform and underscores its great potential for cancer immunotherapy.https://doi.org/10.1038/s41467-025-56110-7
spellingShingle Yizhang Tang
Xujiang Yu
Liangrui He
Meng Tang
Wenji Yue
Ruitong Chen
Jie Zhao
Qi Pan
Wanwan Li
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
Nature Communications
title A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
title_full A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
title_fullStr A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
title_full_unstemmed A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
title_short A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
title_sort high valence bismuth v nanoplatform triggers cancer cell death and anti tumor immune responses with exogenous excitation free endogenous h2o2 and o2 independent ros generation
url https://doi.org/10.1038/s41467-025-56110-7
work_keys_str_mv AT yizhangtang ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT xujiangyu ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT liangruihe ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT mengtang ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT wenjiyue ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT ruitongchen ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT jiezhao ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT qipan ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT wanwanli ahighvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT yizhangtang highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT xujiangyu highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT liangruihe highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT mengtang highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT wenjiyue highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT ruitongchen highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT jiezhao highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT qipan highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration
AT wanwanli highvalencebismuthvnanoplatformtriggerscancercelldeathandantitumorimmuneresponseswithexogenousexcitationfreeendogenoush2o2ando2independentrosgeneration